BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19571663)

  • 1. Abnormal iron uptake and liver cancer.
    Chen J; Chloupková M
    Cancer Biol Ther; 2009 Sep; 8(18):1699-708. PubMed ID: 19571663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C
    Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemochromatosis and transferrin receptor 2.
    Chen J; Enns CA
    Biochim Biophys Acta; 2012 Mar; 1820(3):256-63. PubMed ID: 21864651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.
    Shpyleva SI; Muskhelishvili L; Tryndyak VP; Koturbash I; Tokar EJ; Waalkes MP; Beland FA; Pogribny IP
    Toxicol Sci; 2011 Oct; 123(2):433-40. PubMed ID: 21785164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
    Herrmann T; Muckenthaler M; van der Hoeven F; Brennan K; Gehrke SG; Hubert N; Sergi C; Gröne HJ; Kaiser I; Gosch I; Volkmann M; Riedel HD; Hentze MW; Stewart AF; Stremmel W
    J Mol Med (Berl); 2004 Jan; 82(1):39-48. PubMed ID: 14618243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis.
    Ludwiczek S; Theurl I; Bahram S; Schümann K; Weiss G
    J Cell Physiol; 2005 Aug; 204(2):489-99. PubMed ID: 15744772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-HFE hepatic iron overload.
    Pietrangelo A; Caleffi A; Corradini E
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the regulation of iron homeostasis.
    Deicher R; Hörl WH
    Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of body iron homeostasis by hepcidin].
    Lipiński P; Starzyński RR
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():65-73. PubMed ID: 15069380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin and disorders of iron metabolism.
    Ganz T; Nemeth E
    Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.
    Ryan JD; Ryan E; Fabre A; Lawless MW; Crowe J
    Hepatology; 2010 Oct; 52(4):1266-73. PubMed ID: 20658468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
    Kawabata H
    Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
    Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
    Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.
    Franchini M
    Am J Hematol; 2006 Mar; 81(3):202-9. PubMed ID: 16493621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
    Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
    Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.